Table 5.

Therapy of 174 renal transplant recipients with mucormycosis

Therapy	Patient number	Survived/total number
Amphotericin B formulation
Deoxycholate	78/174(44.8%)	37/78(47.4%)
Lipid	64/174(36.8%)	47/64(73.4%)
Posaconazole	13/174(7.5%)	12/13(92.3%)
Itraconazole, voriconazole, fluconazole, encanocandins, and no antifungal therapy	19/174(11.0%)	4/19(21.1%)
Surgery alone	11/174(6.3%)	4/11(36.4%)
Surgery and antifungal therapy	121/174(69.5%)	85/121(70.2%)
Antifungal alone	34/174(19.5%)	11/34(32.4%)
None	8/174(4.6%)	0/8(0%)